Insights

Growing Market Potential Neurovalens is positioned within the rapidly expanding health-tech sector focused on non-invasive neurostimulation treatments, especially for sleep disorders and insomnia. This trend indicates significant sales opportunities with healthcare providers, clinics, and patients seeking drug-free therapeutic options.

Innovative Product Line With the recent launch of Modius Sleep and upcoming products like Modius Calm, the company offers a diverse portfolio addressing various neurological conditions. This provides multiple avenues for sales expansion across different segments such as sleep clinics, mental health providers, and home healthcare.

Recognition and Validation Receiving awards like the NSF SleepTech Award and participation in major industry events like CES positions Neurovalens as a credible innovator, streamlining partner and customer engagement and facilitating sales through enhanced brand credibility.

Funding and Growth Opportunities Neurovalens has secured significant investment of over $6.8M which supports product development, market penetration, and sales growth strategies. The funding momentum suggests strong investor confidence and potential for scaling sales efforts into new territories.

Alignment with Healthcare Trends The company's non-invasive approach aligns with current healthcare trends favoring minimally invasive therapies and digital health solutions. Targeting health systems, VA programs, and professional healthcare channels can unlock new revenue streams and expand market reach.

Neurovalens Tech Stack

Neurovalens uses 8 technology products and services including Complianz, GitLab CI, MySQL, and more. Explore Neurovalens's tech stack below.

  • Complianz
    A/B Testing
  • GitLab CI
    Continuous Integration
  • MySQL
    Database
  • Apple iCloud Mail
    Email
  • PHP
    Programming Languages
  • Android
    Programming Languages
  • hCaptcha
    Security
  • Vimeo
    Video Players

Media & News

Neurovalens's Email Address Formats

Neurovalens uses at least 1 format(s):
Neurovalens Email FormatsExamplePercentage
First.Last@neurovalens.comJohn.Doe@neurovalens.com
92%
Last@neurovalens.comDoe@neurovalens.com
8%

Frequently Asked Questions

Where is Neurovalens's headquarters located?

Minus sign iconPlus sign icon
Neurovalens's main headquarters is located at Belfast, Northern Ireland United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Neurovalens's official website and social media links?

Minus sign iconPlus sign icon
Neurovalens's official website is neurovalens.com and has social profiles on LinkedInCrunchbase.

What is Neurovalens's NAICS code?

Minus sign iconPlus sign icon
Neurovalens's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Neurovalens have currently?

Minus sign iconPlus sign icon
As of April 2026, Neurovalens has approximately 26 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: J. M.Chief Technology Officer: C. M.Chief Project Officer: I. H.. Explore Neurovalens's employee directory with LeadIQ.

What industry does Neurovalens belong to?

Minus sign iconPlus sign icon
Neurovalens operates in the Medical Equipment Manufacturing industry.

What technology does Neurovalens use?

Minus sign iconPlus sign icon
Neurovalens's tech stack includes ComplianzGitLab CIMySQLApple iCloud MailPHPAndroidhCaptchaVimeo.

What is Neurovalens's email format?

Minus sign iconPlus sign icon
Neurovalens's email format typically follows the pattern of First.Last@neurovalens.com. Find more Neurovalens email formats with LeadIQ.

How much funding has Neurovalens raised to date?

Minus sign iconPlus sign icon
As of April 2026, Neurovalens has raised $6.8M in funding. The last funding round occurred on Aug 19, 2025 for $6.8M.

When was Neurovalens founded?

Minus sign iconPlus sign icon
Neurovalens was founded in 2013.

Neurovalens

Medical Equipment ManufacturingNorthern Ireland, United Kingdom11-50 Employees

Neurovalens is a global health-tech company focused on developing non-invasive neurostimulation products to solve some of the world’s most significant health challenges. The company’s Modius technology is FDA-cleared, non-invasive, and influences the deep parts of the brain with a small and safe electrical pulse. The noninvasive approach removes the need for surgical implantation and allows much earlier intervention in the treatment pathway.

Neurovalens is currently working to release several versions of the technology to treat various disorders. Modius Sleep is the first product to be released in October of 2024. The Neurovalens headquarters is in Belfast, United Kingdom. 
Product Line:
● Modius Sleep (released October 2024)
● Modius Calm (release date TBD)

About Modius Sleep
Modius Sleep is a non-invasive, drug free, physician-prescribed medical device that can help improve sleep for patients with chronic insomnia. Worn as a headset for 30 minutes each evening, it stimulates sleep neurons deep in the brain by using electrical vestibular nerve stimulation (VeNS), which is a non-invasive therapeutic method. The device sends a safe electrical pulse into the vestibular nerve, influencing the areas of the hypothalamus and brainstem that control circadian rhythm and sleep patterns. The neurostimulation is delivered through two self-adhesive electrode pads, which are placed on the skin behind each ear.

Section iconCompany Overview

Headquarters
Belfast, Northern Ireland United Kingdom
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $6.8M

    Neurovalens has raised a total of $6.8M of funding over 11 rounds. Their latest funding round was raised on Aug 19, 2025 in the amount of $6.8M.

  • $1M$10M

    Neurovalens's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $6.8M

    Neurovalens has raised a total of $6.8M of funding over 11 rounds. Their latest funding round was raised on Aug 19, 2025 in the amount of $6.8M.

  • $1M$10M

    Neurovalens's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.